Emmett et al., 1995 - Google Patents

Specific molecular mass detection of endogenously released neuropeptides using in vivo microdialysis/mass spectrometry

Emmett et al., 1995

Document ID
15753755888827766611
Author
Emmett M
Andrén P
Caprioli R
Publication year
Publication venue
Journal of neuroscience methods

External Links

Snippet

The specific molecular detection of the endogenous neuropeptides methionine ([Met] 5) enkephalin and neurotensin released in vivo in rat brain has been accomplished using microdialysis and mass spectrometry. Microdialysis probes were implanted in specific brain …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Emmett et al. Specific molecular mass detection of endogenously released neuropeptides using in vivo microdialysis/mass spectrometry
Kubáň et al. Capillary electrophoresis of small ions and molecules in less conventional human body fluid samples: A review
AU2003256819B2 (en) Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
Issaq et al. Utility of separation science in metabolomic studies
Hasler et al. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man
CN103392219B (en) Quantitation of insulin by mass spectrometry
Maxwell et al. Regional synthesis of neurotransmitter candidates in the CNS of the moth Manduca sexta
Andrén et al. Determination of extracellular release of neurotensin in discrete rat brain regions utilizing in vivo microdialysis/electrospray mass spectrometry
US20030133871A1 (en) Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
CN102395886B (en) Method for quantifying modified peptides
US8546086B2 (en) Use of neuregulin-β as an indicator and/or target
Qi et al. Quantification of dopamine in brain microdialysates with high-performance liquid chromatography–tandem mass spectrometry
Theurillat et al. Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis
Gaboriau et al. Atmospheric pressure chemical ionization-mass spectrometry method to improve the determination of dansylated polyamines
Desiderio Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid
Andrén et al. Blood–brain barrier penetration of 3‐aminopropyl‐n‐butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry
DE3587091T2 (en) DEVELOPMENT METHOD FOR DRUG TREATMENT MEDICINES.
DE102006021406A1 (en) In vitro methods for the detection and early detection and the concomitant control of the therapy of drug- and addiction-induced liver damage
Kupiec et al. Stereochemical determination of selegiline metabolites in postmortem biological specimens
Umbach et al. Giant synaptosomes
Hare et al. Rapid estimation of DOPA in physiological fluids using the amino acid analyzer
Olivares et al. Isocratic high-performance liquid chromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements
Heydorn et al. Effect of reduction of cholinergic input on the concentration of specific proteins in different cortical regions of the rat brain
Murata et al. Probe electrospray ionization/mass spectrometry and its applications to the life sciences
Wenk et al. [3H] ketanserin binding increases in monkey cortex following basal forebrain lesions with ibotenic acid